By Dr Michael Cardamone

Journal articles

Viswanathan S; Oliver KL; Regan BM; Schneider AL; Myers CT; Mehaffey MG; LaCroix AJ; Antony J; Webster R; Cardamone M; Subramanian GM; Chiu ATG; Roza E; Teleanu RI; Malone S; Leventer RJ; Gill D; Berkovic SF; Hildebrand MS; Goad BS; Howell KB; Symonds JD; Brunklaus A; Sadleir LG; Zuberi SM; Mefford HC; Scheffer IE, 2024, 'Solving the Etiology of Developmental and Epileptic Encephalopathy with Spike–Wave Activation in Sleep (D/EE-SWAS)', Annals of Neurology, 96, pp. 932 - 943, http://dx.doi.org/10.1002/ana.27041

Tsang E; Han VX; Flutter C; Alshammery S; Keating BA; Williams T; Gloss BS; Graham ME; Aryamanesh N; Pang I; Wong M; Winlaw D; Cardamone M; Mohammad S; Gold W; Patel S; Dale RC, 2024, 'Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome', eBioMedicine, 104, http://dx.doi.org/10.1016/j.ebiom.2024.105156

Farrar TE; D'Silva A; Cardamone M; Bartley ML; Wong CH; Farrar MA, 2024, 'Clinician Understanding, Acceptance and utilization of Ketogenic diet therapy for epilepsy in Australia and New Zealand: An online survey', Epilepsy and Behavior Reports, 28, http://dx.doi.org/10.1016/j.ebr.2024.100711

Menzies J; Sundararaj A; Cardamone M; McHarg A; Leach S; Krishnan U, 2023, 'Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life', Journal of Pediatric Gastroenterology and Nutrition, 77, pp. 679 - 685, http://dx.doi.org/10.1097/MPG.0000000000003928

Forwood C; Ashton K; Zhu Y; Zhang F; Dias KR; Standen K; Evans CA; Carey L; Cardamone M; Shalhoub C; Katf H; Riveros C; Hsieh TC; Krawitz P; Robinson PN; Dudding-Byth T; Sadikovic B; Pinner J; Buckley MF; Roscioli T, 2023, 'Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re-classification of an ARID1B missense variant', American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 193, http://dx.doi.org/10.1002/ajmg.c.32056

Hosie PH; Lim C; Scott TRD; Cardamone M; Farrar MA; Frith C; Andrews PI; Pinner J; Pillai S, 2023, 'Treatment of severe acute necrotizing encephalopathy of childhood with interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows favorable long-term outcome at 2 years', Brain and Development, 45, pp. 401 - 407, http://dx.doi.org/10.1016/j.braindev.2023.03.002

Oliver KL; Trivisano M; Mandelstam SA; De Dominicis A; Francis DI; Green TE; Muir AM; Chowdhary A; Hertzberg C; Goldhahn K; Metreau J; Prager C; Pinner J; Cardamone M; Myers KA; Leventer RJ; Lesca G; Bahlo M; Hildebrand MS; Mefford HC; Kaindl AM; Specchio N; Scheffer IE, 2023, 'WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk', Epilepsia, 64, pp. 1351 - 1367, http://dx.doi.org/10.1111/epi.17542

Scheffer IE; Bennett CA; Gill D; de Silva MG; Boggs K; Marum J; Baker N; Palmer EE; Howell KB; Andrews I; Antony J; Ardern-Holmes S; Bye AM; Cardamone M; Chelakkadan S; Clark D; Curnow SR; Dabscheck G; Fahey MC; Freeman JL; Gupta S; Harvey AS; Hildebrand MS; Inder M; Kanhangad M; Kornberg AJ; Kothur K; Lawson JA; Leventer RJ; Malone S; Menezes MP; Mohammad S; Nagarajan L; Pillai S; Pridmore C; Procopis PG; Sampaio H; Silberstein J; Sinclair A; Smith N; Subramanian G; Troedson C; Ware T; White SM, 2023, 'Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice', Developmental Medicine and Child Neurology, 65, pp. 50 - 57, http://dx.doi.org/10.1111/dmcn.15308

Briest RC; Cheung AK; Kandula T; Cardamone M; Pillai SC; Sampaio H; Teoh HL; Webster RI; Wenderoth J; Andrews PI, 2023, 'Urgent computed tomography angiography in paediatric stroke', Developmental Medicine and Child Neurology, 65, pp. 126 - 135, http://dx.doi.org/10.1111/dmcn.15285

Uppal P; Cardamone M; Fonseca B; Briggs N; A Lawson J, 2022, 'The need for improved management of status epilepticus in children in Australia: Time from seizure onset to treatment is consistently delayed', Journal of Paediatrics and Child Health, 58, pp. 261 - 266, http://dx.doi.org/10.1111/jpc.15697

Palmer EE; Sachdev R; Macintosh R; Melo US; Mundlos S; Righetti S; Kandula T; Minoche AE; Puttick C; Gayevskiy V; Hesson L; Idrisoglu S; Shoubridge C; Thai MHN; Davis RL; Drew AP; Sampaio H; Andrews PI; Lawson J; Cardamone M; Mowat D; Colley A; Kummerfeld S; Dinger ME; Cowley MJ; Roscioli T; Bye A; Kirk E, 2021, 'Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies', Neurology, 96, pp. E1770 - E1782, http://dx.doi.org/10.1212/WNL.0000000000011655

Singh P; Numa A; Pethani B; Bye A; Cardamone M; Flanagan D, 2021, 'P0006 / #556: ASSESSING THE LOGISTICS, FEASIBILITY AND CHALLENGES OF ESTABLISHING CONTINUOUS EEG SERVICE IN A CHILDREN’S ICU', Pediatric Critical Care Medicine, 22, pp. 40 - 40, http://dx.doi.org/10.1097/01.pcc.0000738368.99382.28

Macdonald-Laurs E; Wenderoth J; Cardamone M; Sampaio H; Andrews PI, 2020, 'Endovascular clot retrieval for acute ischaemic stroke due to basilar artery occlusion in childhood', Developmental Medicine and Child Neurology, 62, pp. 1221 - 1223, http://dx.doi.org/10.1111/dmcn.14449

Ngu F; Cardamone M; Wanaguru D; Currie B; Wegner EA; Andrews I; Haindl W, 2020, 'Medically resistant juvenile myasthenia gravis following thymectomy: Role for FDG PET/CT', Journal of Pediatric Surgery Case Reports, 59, http://dx.doi.org/10.1016/j.epsc.2020.101494

Uppal P; Cardamone M; Webber C; Briggs N; Lawson JA, 2019, 'Management of status epilepticus in children prior to medical retrieval: Deviations from the guidelines', Journal of Paediatrics and Child Health, 55, pp. 1458 - 1462, http://dx.doi.org/10.1111/jpc.14448

Banuelos R; Beavis E; Le Marne F; Rowe N; Gao Y; Menzies J; Farrar MA; Cardamone M, 2019, 'Factors Affecting the Efficacy, Tolerability and Compliance of Dietary Therapy for Epilepsy- Four-Years Experience', Neurological Case Reports, 2, pp. 1010 - 1010, http://www.remedypublications.com/neurological-case-reports-abstract.php?aid=4936

Chen KA; Farrar M; Cardamone M; Gill D; Smith R; Cowell CT; Truong L; Lawson JA, 2018, 'Cannabidiol for treating drug-resistant epilepsy in children: The New South Wales experience', Medical Journal of Australia, 209, pp. 217 - 221, http://dx.doi.org/10.5694/mja18.00023

Ho G; Carey K; Cardamone M; Farrar M, 2018, 'Myotonic dystrophy type 1: clinical manifestations in children and adolescents', Archives of Disease in Childhood, 104, pp. 48 - 52, http://dx.doi.org/10.1136/archdischild-2018-314837

Uppal P; Cardamone M; Lawson JA, 2018, 'Outcomes of deviation from treatment guidelines in status epilepticus: A systematic review', Seizure, 58, pp. 147 - 153, http://dx.doi.org/10.1016/j.seizure.2018.04.005

Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK; Palmer E, 2018, 'Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness', Molecular Genetics and Genomic Medicine, 6, pp. 186 - 199, http://dx.doi.org/10.1002/mgg3.355

Gennarino VA; Palmer EE; McDonell LM; Wang L; Adamski CJ; Koire A; See L; Chen CA; Schaaf CP; Rosenfeld JA; Panzer JA; Moog U; Hao S; Bye A; Kirk EP; Stankiewicz P; Breman AM; McBride A; Kandula T; Dubbs HA; Macintosh R; Cardamone M; Zhu Y; Ying K; Dias KR; Cho MT; Henderson LB; Baskin B; Morris P; Tao J; Cowley MJ; Dinger ME; Roscioli T; Caluseriu O; Suchowersky O; Sachdev RK; Lichtarge O; Tang J; Boycott KM; Holder JL; Zoghbi HY; Palmer E, 2018, 'A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures', Cell, 172, pp. 924 - 936.e11, http://dx.doi.org/10.1016/j.cell.2018.02.006

Chen KA; Farrar MA; Cardamone M; Lawson J, 2018, 'Cannabis for paediatric epilepsy: challenges and conundrums', The Medical journal of Australia, http://dx.doi.org/10.5694/mja17.00699

Asakai H; Stojanovski B; Galati JC; Zannino D; Cardamone M; Hutchinson D; Cheung MMH; Mackay MT, 2017, 'Risk Factors for Peri-Procedural Arterial Ischaemic Stroke in Children with Cardiac Disease', Pediatric Cardiology, 38, pp. 1385 - 1392, http://dx.doi.org/10.1007/s00246-017-1674-x

Ho G; Widger J; Cardamone M; Farrar MA, 2017, 'Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1', Sleep Medicine, 32, pp. 92 - 96, http://dx.doi.org/10.1016/j.sleep.2016.12.005

Farrar MA; Ho G; Widger J; Cardamone M, 2016, 'Quality of life and excessive daytime sleepiness in children and adolescents with Myotonic dystrophy type 1', Sleep Medicine, 32, pp. 92 - 96, http://dx.doi.org/10.1016/j.sleep.2016.12.005

Farrar MA; Teoh HL; Brammah S; Roscioli T; Cardamone M, 2016, 'Glial mitochondropathy in infantile neuroaxonal dystrophy: Pathophysiological and therapeutic implications', Brain, 139, pp. e67, http://dx.doi.org/10.1093/brain/aww174

Le Marne FA; McGinness H; Slade R; Cardamone M; Balbir Singh S; Connolly AM; Bye AME, 2016, 'Evaluation of an E-learning resource on approach to the first unprovoked seizure', Journal of Paediatrics and Child Health, 52, pp. 896 - 900, http://dx.doi.org/10.1111/jpc.13277

Cardamone M; Asakai H; Hutchinson D; Stojanovski B; Galati JC; Cheung MMH; MacKay MT, 2015, 'Arterial ischemic stroke in children with cardiac disease', Neurology, 85, pp. 2053 - 2059, http://dx.doi.org/10.1212/WNL.0000000000002036

Ho G; Cardamone M; Farrar M, 2015, 'Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.', World J Clin Pediatr, 4, pp. 66 - 80, http://dx.doi.org/10.5409/wjcp.v4.i4.66

Palmer EE; Hayner J; Sachdev R; Cardamone M; Kandula T; Morris P; Dias KR; Tao J; Miller D; Zhu Y; Macintosh R; Dinger ME; Cowley MJ; Buckley MF; Roscioli T; Bye A; Kilberg MS; Kirk EP; Palmer E, 2015, 'Asparagine Synthetase Deficiency causes reduced proliferation of cells under conditions of limited asparagine', Molecular Genetics and Metabolism, 116, pp. 178 - 186, http://dx.doi.org/10.1016/j.ymgme.2015.08.007

Wibisono C; Rowe N; Beavis E; Kepreotes H; Mackie FE; Lawson JA; Cardamone M, 2015, 'Ten-year single-center experience of the ketogenic diet: Factors influencing efficacy, tolerability, and compliance', Journal of Pediatrics, 166, pp. 1030 - 1036.e1, http://dx.doi.org/10.1016/j.jpeds.2014.12.018

Asakai H; Stojanovski B; Galati JC; Cardamone M; Hutchinson D; Cheung MM; Mackay MT, 2015, 'Abstract T P375: Risk Factors for Peri-procedural Stroke in Children With Cardiac Disease', Stroke, 46, http://dx.doi.org/10.1161/str.46.suppl_1.tp375

Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA, 2014, 'Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex', Journal of Pediatrics, 164, pp. 1195 - 1200, http://dx.doi.org/10.1016/j.jpeds.2013.12.053

Kamien BA; Cardamone DM; Lawson JA; Sachdev RR, 2012, 'A genetic diagnostic approach to infantile epileptic encephalopathies', Journal of Clinical Neuroscience, 19, pp. 934 - 941, http://dx.doi.org/10.1016/j.jocn.2012.01.017

Hutchinson D; Cheung M; Cardamone M; Mackay M; Barnes C; Coleman L, 2011, 'Arterial Ischaemic Stroke in Children with Heart Disease: Experience in a Single Centre Over 17 Years', Heart, Lung and Circulation, 20, pp. S233 - S234, http://dx.doi.org/10.1016/j.hlc.2011.05.574

Cardamone M; Hutchinson D; Cheung M; Coleman L; Mackay MT, 2009, '35. Preliminary findings: a retrospective study of ischaemic stroke in children with congenital and acquired cardiac disease', Journal of Clinical Neuroscience, 16, pp. 1536 - 1537, http://dx.doi.org/10.1016/j.jocn.2009.07.060

Cardamone M; Alex G; Harari MD; Moss WP; Oliver MR, 2008, 'Severe iron-deficiency anaemia in adolescents: Consider Helicobacter pylori infection', Journal of Paediatrics and Child Health, 44, pp. 647 - 650, http://dx.doi.org/10.1111/j.1440-1754.2008.01374.x

Cardamone M; Darras BT; Ryan MM, 2008, 'Inherited myopathies and muscular dystrophies', Seminars in Neurology, 28, pp. 250 - 259, http://dx.doi.org/10.1055/s-2008-1062269

Cardamone M; Lee RP; Lucas JC; Birks DVA; O'Donoghue M; Lofthouse SA; Brandon MR, 1998, 'Sustained-release delivery systems and their application for endoparasite control in animals', Journal of Controlled Release, 51, pp. 73 - 83, http://dx.doi.org/10.1016/S0168-3659(97)00160-0

Cardamone M; Lofthouse SA; Lucas JC; Lee RP; O'Donoghue M; Brandon MR, 1997, 'In vitro testing of a pulsatile delivery system and its in vivo application of immunisation against tetanus toxoid', Journal of Controlled Release, 47, pp. 205 - 219, http://dx.doi.org/10.1016/S0168-3659(97)01639-8

Cardamone M; Brandon MR; Puri NK, 1995, 'Comparing the Refolding and Reoxidation of Recombinant Porcine Growth Hormone from a Urea Denatured State and from Escherichia Coli Inclusion Bodies', Biochemistry, 34, pp. 5773 - 5794, http://dx.doi.org/10.1021/bi00017a009

Cardamone M; Puri NK; Sawyer WH; Capon RJ; Brandon MR, 1994, 'A spectroscopic and equilibrium binding analysis of cationic detergent-protein interactions using soluble and insoluble recombinant porcine growth hormone', Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 1206, pp. 71 - 82, http://dx.doi.org/10.1016/0167-4838(94)90074-4

Cardamone M; Degen T; O'Donoghue MF; Brandon MR, 1994, 'Development of a pulsatile drug delivery system for veterinary pharmaceuticals', Proceedings of the Controlled Release Society, pp. 833 - 834

Cardamone M; Ashman K; Brandon MR; Puri NK, 1993, 'Identification of cysteine-containing peptides during the peptide mapping of recombinant proteins', Peptide Research, 6, pp. 242 - 248

Puri NK; Cardamone M; Crivelli E; Traeger JC, 1993, 'Characterization of a truncated form of recombinant porcine growth hormone generated in vitro during solubilization of inclusion bodies', Protein Expression and Purification, 4, pp. 164 - 175, http://dx.doi.org/10.1006/prep.1993.1023

Puri NK; Cardamone M, 1992, 'A relationship between the starting secondary structure of recombinant porcine growth hormone solubilised from inclusion bodies and the yield of native (monomeric) protein after in vitro refolding', FEBS Letters, 305, pp. 177 - 180, http://dx.doi.org/10.1016/0014-5793(92)80661-Y

Purl NK; Crivelli E; Cardamone M; Fiddes R; Bertolini J; Ninham B; Brandon MR, 1992, 'Solubilization of growth hormone and other recombinant proteins from Escherichia coli inclusion bodies by using a cationic surfactant', Biochemical Journal, 285, pp. 871 - 879, http://dx.doi.org/10.1042/bj2850871

Cardamone M; Puri NK, 1992, 'Spectrofluorimetric assessment of the surface hydrophobicity of proteins', Biochemical Journal, 282, pp. 589 - 593, http://dx.doi.org/10.1042/bj2820589

Crivelli E; Cardamone M; Puri NK, 1991, 'A single step method for the solubilization and refolding of recombinant protein from E. coli inclusion bodies.', Australian journal of biotechnology, 5

Conference Papers

Farrar T; D'Silva A; Cardamone M; Bartley M; Wong C; Farrar M, 2024, '2959 Clinician understanding, acceptance and utilization of ketogenic diet therapy for epilepsy in Australia and New Zealand: a cross-sectional cohort study', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A5.3 - A5, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.13

Back to profile page